LATEST UPDATES » Vol 26, Nos. 05 & 06, May & June 2022 – Living Better for Longer: Cutting-Edge Research in Geriatric Medicine       » How Oxidation Can Lead to Mitochondrial Dysfunction and Age-Dependent Cognitive Disorders       » New Semiconductor Microchip Detects Prostate Cancer Markers With Ultra-High Sensitivity       » New Method for Synthesising Sulphur-Based Medicines Can Boost Drug Discovery Efficiency and Speed       » Selecting the Best Target for Deep Brain Stimulation in Parkinson’s Disease       » A Single Metabolite Can Promote Tissue Regeneration and Delay Ageing       » A New Light-Sensitive Way to Control Parathyroid Hormone Secretion for the Prevention of Bone Loss      
Vol 26, Nos. 05 & 06, May & June 2022   |   Issue PDF view/purchase
New Imaging Method to Diagnose Disabling Brain Condition Offers Hope of Improved Patient Outcomes
SGH and NNI researchers have developed a new, non-invasive neuroimaging method to better diagnose iNPH, which could facilitate early intervention and treatment.

A team of researchers from the Singapore General Hospital (SGH) and the National Neuroscience Institute (NNI) have developed a new method to diagnose and assess Idiopathic Normal Pressure Hydrocephalus (iNPH), a neurological condition that results in excess cerebrospinal fluid (CSF) accumulating in the brain’s ventricles.

The ventricles are fluid-filled cavities located deep within the brain, which appear as a central butterfly-shaped-like structure on brain scans. Excess CSF in these fluid-filled cavities causes the ventricles to enlarge, and the butterfly wings to balloon. This causes the nerve fibre tracts that run alongside the dilated ventricles to stretch, resulting in symptoms such as cognitive decline, walking difficulties and urinary incontinence, among other symptoms. However, some of the mental and gait symptoms overlap with those seen in the more common Parkinson’s disease and Alzheimer’s disease, which can delay diagnosis.

“The correct diagnosis of iNPH is essential to ensuring appropriate management for this condition. In some cases, iNPH can be controlled or reversed with the insertion of a shunt to drain excess CSF from the brain,” said Dr. Nicole Keong, Senior Consultant, Department of Neurosurgery, NNI and research co-lead. “However, other conditions may mimic iNPH. In addition, the treatment for iNPH involves surgery, which carries the risk of complications such as infection or bleeding in the brain, so determining which patients would most benefit from shunt insertion is an important part of the supplementary testing needed to avoid unnecessary risks to patients. Brain imaging is one of the most critical tools we rely on to address this need.”

Conventionally, brain imaging methods to diagnose iNPH are often imprecise and result in a lot of variabilities.

Researchers from SGH and NNI have developed a new method to measure the ventricular dilatation in iNPH by focusing on the narrowed space at the back (also known as splenial) end of the ventricles, and measuring it on the horizontal plane. This is termed the splenial angle, which they found to be narrower in iNPH patients than in patients with Alzheimer’s and Parkinson’s disease, or healthy elderly.

“Brain images are most commonly acquired in the horizontal plane as the patient lies flat on the scanner table. Leveraging this, we developed a neuroimaging method to measure the narrowed space between the dilated ventricles which leads to a more reproducible and reliable method for diagnosis of iNPH, and differentiating from other neurodegenerative conditions,” said Associate Professor Chan Ling Ling, Senior Consultant, Department of Diagnostic Radiology, SGH and research lead. She is also an Associate Professor in the Radiological Sciences, Academic Clinical Programme and Neuroscience & Behavioural Disorders, Signature Research Programme, Duke-NUS Medical School.

The researchers found the splenial angle to be better than current existing radiological methods of detecting and assessing iNPH, with superior accuracy in differentiating iNPH from Alzheimer’s disease and Parkinson’s disease. This could improve screening for iNPH on neuroimaging, and potentially impact patient outcomes.

Source: National Neuroscience Institute

news Medtec China 2022 Is Now Open for Visitor Registration, Helping Medical Device Manufacturers in Medtech Sourcing and Supply Chain Stabilisation
news Inaugural Asia Summit on Global Health highlights Hong Kong's advantages
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy